During its analysts' meeting in New York last month, St. Jude Medical (St. Paul, Minnesota) provided a detailed review of its worldwide operations. It specifically noted that atrial fibrillation (AF) is an important platform for its future growth, noting that "after heart failure, AF represents the largest unmet clinical need in cardiovascular medicine today."